Daiwa Securities Group Inc. Cuts Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Daiwa Securities Group Inc. trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 7.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 79,858 shares of the medical equipment provider's stock after selling 6,399 shares during the period. Daiwa Securities Group Inc.'s holdings in Intuitive Surgical were worth $41,683,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Bennett Selby Investments LP lifted its stake in shares of Intuitive Surgical by 3.9% in the 4th quarter. Bennett Selby Investments LP now owns 449 shares of the medical equipment provider's stock valued at $234,000 after purchasing an additional 17 shares during the last quarter. Onefund LLC raised its holdings in shares of Intuitive Surgical by 1.9% in the fourth quarter. Onefund LLC now owns 947 shares of the medical equipment provider's stock worth $494,000 after buying an additional 18 shares during the period. LVW Advisors LLC raised its holdings in shares of Intuitive Surgical by 1.3% in the fourth quarter. LVW Advisors LLC now owns 1,448 shares of the medical equipment provider's stock worth $756,000 after buying an additional 19 shares during the period. Wesbanco Bank Inc. raised its holdings in shares of Intuitive Surgical by 1.6% in the fourth quarter. Wesbanco Bank Inc. now owns 1,216 shares of the medical equipment provider's stock worth $635,000 after buying an additional 19 shares during the period. Finally, FSM Wealth Advisors LLC raised its holdings in shares of Intuitive Surgical by 3.7% in the fourth quarter. FSM Wealth Advisors LLC now owns 526 shares of the medical equipment provider's stock worth $275,000 after buying an additional 19 shares during the period. 83.64% of the stock is owned by institutional investors.

Remove Ads

Insider Activity

In related news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares in the company, valued at $6,955,015. The trade was a 27.41 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction dated Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares of the company's stock, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 22,209 shares of company stock valued at $11,928,127 in the last quarter. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Stock Up 0.7 %

Shares of ISRG stock traded up $3.58 on Wednesday, hitting $497.30. The company had a trading volume of 2,557,102 shares, compared to its average volume of 1,425,013. The firm has a market cap of $177.13 billion, a P/E ratio of 77.58, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The company has a 50-day moving average price of $569.42 and a 200-day moving average price of $531.60. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on ISRG. Truist Financial increased their price target on Intuitive Surgical from $640.00 to $666.00 and gave the stock a "buy" rating in a report on Friday, January 24th. Bernstein Bank raised their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a report on Monday, January 27th. UBS Group raised their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a "neutral" rating in a report on Monday, January 27th. Piper Sandler restated an "overweight" rating and set a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, Morgan Stanley upgraded Intuitive Surgical from an "equal weight" rating to an "overweight" rating and raised their price objective for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have assigned a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.